APPLIED DNA SCIENCES INC's ticker is and the CUSIP is 03815U300. A total of 20 filers reported holding APPLIED DNA SCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $633,666 | -3.0% | 523,691 | +3.4% | 0.00% | – |
| Q2 2023 | $653,321 | +14.2% | 506,450 | 0.0% | 0.00% | – |
| Q1 2023 | $572,288 | -31.9% | 506,450 | 0.0% | 0.00% | – |
| Q4 2022 | $840,707 | +110.7% | 506,450 | +43.4% | 0.00% | – |
| Q3 2022 | $399,000 | +155.8% | 353,050 | +67.3% | 0.00% | – |
| Q2 2022 | $156,000 | -65.9% | 211,050 | -1.3% | 0.00% | – |
| Q1 2022 | $458,000 | -58.1% | 213,750 | -21.4% | 0.00% | – |
| Q4 2021 | $1,094,000 | -25.5% | 272,066 | -0.1% | 0.00% | – |
| Q3 2021 | $1,468,000 | -20.1% | 272,417 | +0.7% | 0.00% | – |
| Q2 2021 | $1,838,000 | +43.8% | 270,629 | +52.2% | 0.00% | – |
| Q1 2021 | $1,278,000 | +59.0% | 177,833 | +12.8% | 0.00% | – |
| Q4 2020 | $804,000 | -25.2% | 157,597 | +13.3% | 0.00% | – |
| Q3 2020 | $1,075,000 | -0.7% | 139,096 | +3.6% | 0.00% | – |
| Q2 2020 | $1,083,000 | +161.6% | 134,202 | +30.2% | 0.00% | – |
| Q1 2020 | $414,000 | +3.2% | 103,100 | +7.7% | 0.00% | – |
| Q4 2019 | $401,000 | – | 95,694 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 751,780 | $849,511 | 0.12% |
| SABBY MANAGEMENT, LLC | 73,553 | $83,115 | 0.07% |
| Cowen Prime Advisors LLC | 98,301 | $95 | 0.04% |
| Atria Wealth Solutions, Inc. | 81,210 | $91,767 | 0.00% |
| Advisory Services Network, LLC | 1 | $1 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 50,892 | $57,508 | 0.00% |
| UBS Group AG | 12,188 | $13,772 | 0.00% |
| NewEdge Advisors, LLC | 2 | $2 | 0.00% |
| Moisand Fitzgerald Tamayo, LLC | 2,000 | $2,260 | 0.00% |
| OSAIC HOLDINGS, INC. | 2 | $2 | 0.00% |